Oligonucleotide therapeutics for human leukaemia

CIBA Foundation Symposia

Volumn , Issue 209, 1997, Pages 169-194

  Gewirtz, Alan M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; ONCOPROTEIN; PROTEIN C MYB; TRANSACTIVATOR PROTEIN;

ANIMAL; GENETICS; HUMAN; LEUKEMIA; REVIEW;

ANIMALS; ANTINEOPLASTIC AGENTS; HUMANS; LEUKEMIA; OLIGONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MYB; TRANS-ACTIVATORS;

EID: 0031303284     PISSN: 03005208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Anfossi G, Gewirtz, AM, Calabretta B 1989 An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines. Proc Natl Acacl Sci USA 86:3379-3383
2. Barletta C, Pelicci PG, Kenyon LC, Smith SD, Dalla-Favera R 1987 Relationship between the c-myb locus and the 6q-chromosomal aberration in leukemias and lymphomas. Science 235:1064-1067
3. Baskerville S, Ellington AD 1995 RNA structure. Describing the elephant. Curr Biol 5:120-123
4. Bedi A, Zehnbauer BA, Collector MI et al 1993 Bcr-Abl gene rearrangement and expression of primitive hematopoietic progenitors in chronic myeloid leukemia. Blood 81:2898-2902
5. Beltinger C, Saragovi HU, Smith RM et al 1995 Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides. J Clin Invest 95:1814-1823
6. Bergan R, Hakim F, Schwartz GN et al 1996 Electroporation of synthetic oligodeoxynucleotides: a novel technique for ex vivo bone marrow purging. Blood 88:731-741
7. Biedenkapp H, Borgmeyer U, Sippel AE, Klempnauer KH 1988 Viral myb oncogene encodes a sequence-specific DNA-binding activity. Nature 335:835-837
8. Burk O, Mink S, Ringwald M, Klempnauer KH 1993 Synergistic activation of the chicken MIM-1 gene by v-Myb and C/EBP transcription factors. EMBO J 12:2027-2038
9. Calabretta B, Sims RB, Valtieri M et al 1991 Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging. Proc Natl Acad Sci USA 88:2351-2355
10. Caracciolo D, Venturelli D, Valtieri M, Peschle C, Gewirtz AM, Calabretta B 1990 Stage-related proliferative activity determines c-myb functional requirements during normal human hematopoiesis. J Clin Invest 85:55-61
11. Carson WE, Haldar S, Baiocchi RA, Croce CM, Caligiuri MA 1994 The c-kit ligand suppresses apoptosis of human natural killer cells through the upreguation of bcl-2. Proc Natl Acad Sci USA 91:7553-7557
12. Clarke MF, Kukowska-Latallo JF, Westin E, Smith M, Prochownik EV 1988 Constitutive expression of a c-myb cDNA blocks Friend murine erythroleukemia cell differentiation. Mol Cell Biol 8:884-892
13. Cogswell JP, Cogswell PC, Kuehl WM et al 1993 Mechanism of c-myc regulation by c-myb in different cell lineages. Mol Cell Biol 13:2858-2869
14. Dini PW, Eltman JT, Lipsick JS 1995 Mutations in the DNA-binding and transcriptional activation domains of v-myb cooperate in transformation. J Virol 69:2515-2524
15. Gale RP, Grosveld G, Canaani E, Goldman JM 1993 Chronic myelogenous leukemia: biology and therapy. Leukemia 7:653-658
16. Galli-Taliadoros LA, Sedgwick JD, Wood SA, Korner H 1995 Gene knock-out technology: a methodological overview for the interested novice. J Immunol Methods 181:1-15
17. Gewirtz AM, Calabretta B 1988 A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro. Science 242:1303-1306
18. Gewirtz AM, Anfossi G, Venturelli D, Valpreda S, Sims R, Calabretta B 1989 G1/S transition in normal human T-lymphocytes requires the nuclear protein encoded by c-myb. Science 245:180-183
19. Gewirtz AM, Luger S, Sokol D et al 1996a Oligodeoxynucleotide therapeutics for human myelogenous leukemia: interim results. Blood (suppl) 88:1069
20. Gewirtz AM, Stein CA, Glazer PM 1996b Facilitating oligonucleotide delivery: helping antisense deliver on its promise. Proc Natl Acad Sci USA 93:3161-3163
21. Heyer WD, Kohli J 1994 Homologous recombination. Experientia 50:189-191
22. Hijiya N, Zhang J, Ratajczak MZ et al 1994. Biologic and therapeutic significance of MYB expression in human melanoma. Proc Natl Acad Sci USA 91:4499-4503
23. Kanei-Ishii C, MacMillan EM, Nomura T et al 1992 Transactivation and transformation by Myb are negatively regulated by a leucine-zipper structure. Proc Natl Acad Sci USA 89: 3088-3092
24. Ku DH, Wen SC, Engelhard A et al 1993 c-myb transactivates cdc2 expression via Myb-binding sites in the 5′-flanking region of the human cdc2 gene (published erratum appears in J Biol Chem 1993 268:13010). J Biol Chem 268:2255-2259
25. Lewis JG, Lin K-Y, Kothavale A et al 1996 A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA. Proc Natl Acad Sci USA 93:3176-3181
26. Liebermann DA, Hoffman-Liebermann B 1989 Proto-oncogene expression and dissection of the myeloid growth to differentiation developmental cascade. Oncogene 4:583-592
27. Loke SL, Stein CA, Zhang XH et al 1989 Characterization of oligonucleotide transport into living cells. Proc Natl Acad Sci USA 86:3474-3478
28. Luger SM, Ratajczak J, Ratajczak MZ et al 1996 A functional analysis of protooncogene Vav's role in adult human hematopoiesis. Blood 87:1326-1334
29. Lyon J, Robinson C, Watson R 1994 The role of Myb proteins in normal and neoplastic cell proliferation. Crit Rev Oncog 5:373-388
30. Melo JV 1996 The molecular biology of chronic myeloid leukaemia. Leukemia 10:751-756
31. Melotti P, Ku DH, Calabretta B 1994 Regulation of the expression of the hematopoietic stem cell antigen CD34: role of c-myb. J Exp Med 179:1023-1028
32. Metcalf D 1994 Blood. Thrombopoietin - at last. Nature 369:519-520
33. Morrow B, Kucherlapati R 1993 Gene targeting in mammalian cells by homologous recombination. Curt Opin Biotechnol 4:577-582
34. Mucenski ML, McLain K, Kier AB et al 1991 A functional c-Myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 65:677-689
35. Nakayama K, Yamamoto R, Ishii S, Nakauchi H 1993 Binding of c-Myb to the core sequence of the CD4 promoter. Int Immunol 5:817-824
36. Ness SA, Marknell A, Graf T 1989 The v-Myb oncogene product binds to and activates the promyelocyte-specific Mim-1 gene. Cell 59:1115-1125
37. Ness SA, Kowenz-Leutz E, Casini T, Graf T, Leutz A 1993 Myb and NF-M: combinatorial activators of myeloid genes in heterologous cell types. Genes Dev 7:749-759
38. Nomura N, Zu YL, Maekawa T, Tabata S, Akiyama T, Ishii S 1993 Isolation and characterization of a novel member of the gene family encoding the cAMP response element-binding protein CRE-BP1. J Biol Chem 268:4259-4266
39. Nomura T, Sakai N, Sarai A et al 1993 Negative autoregulation of c-Myb activity by homodimer formation through the leucine zipper. J Biol Chem 268:21914-21923
40. Osman F, Tomsett B, Strike P 1994 Homologous recombination. Prog Ind Microbiol 29:687-732
41. Press RD, Reddy EP, Ewert DL 1994 Overexpression of C-terminally but not N-terminally truncated Myb induces fibrosarcomas: a novel nonhematopoietic target cell for the Myb oncogene. Mol Cell Biol 14:2278-2290
42. Prochownik EV, Smith MJ, Snyder K, Emeagwali D 1990 Amplified expression of three jun family members inhibits erythroleukemia differentiation. Blood 76:1830-1837
43. Ratajczak MZ, Hijiya N, Catani L et al 1992a Acute- and chronic-phase chronic myelogenous leukemia colony-forming units are highly sensitive to the growth inhibitory effects of c-myb antisense oligodeoxynucleotides. Blood 79:1956-1961
44. Ratajczak MZ, Kant JA, Luger SM et al 1992b In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides. Proc Natl Acad Sci USA 89:11823-11827
45. Ratajczak MZ, Luger SM, DeRiel K et al 1992c Role of the KIT protooncogene in normal and malignant human hematopoiesis. Proc Natl Acad Sci USA 89:1710-1714
46. Ratajczak MZ, Luger SM, Gewirtz AM 1992d The c-Kit proto-oncogene in normal and malignant human hematopoiesis. Int J Cell Cloning 10:205-214
47. Sakura H, Kanei-Ishii C, Nagase T, Nakagoshi H, Gonda TJ Ishii S 1989 Delineation of three functional domains of the transcriptional activator encoded by the c-myb protooncogene. Proc Natl Acad Sci USA 86:5758-5762
48. + human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. Proc Natl Acad Sci USA 91:459-463
49. Spiller DG, Tidd DM 1995 Nuclear delivery of antisense oligodeoxynucleotides through reversible permeabilization of human leukemia cells with streptolysin O. Antisense Res Dev 5:13-21
50. Szczylik C, Skorski T, Ku DH et al 1993 Regulation of proliferation and cytokine expression of bone marrow fibroblasts: role of c-myb. J Exp Med 178:997-1005
51. Takeshita K, Bollekens JA, Hijiya N, Ratajczak M, Ruddle FH, Gewirtz AM 1993 A homeobox gene of the Antennapedia class is required for human adult erythropoiesis. Proc Natl Acad Sci USA 90:3535-3538
52. Travail S, Reiss K, Ferber A et al 1991 Constitutively expressed c-myb abrogates the requirement for insulin-like growth factor 1 in 3T3 fibroblasts. Mol Cell Biol 11:731-736
53. Vorbrueggen G, Kalkbrenner F, Guehmann S, Moelling K 1994 The carboxy terminus of human c-myb protein stimulates activated transcription in trans. Nucleic Acids Res 22:2466-2475
54. Weber BL, Westin EH, Clarke MF 1990 Differentiation of mouse erythroleukemia cells enhanced by alternatively spliced c-myb mRNA. Science 249:1291-1293
55. Willnow TE, Herz J 1994 Homologous recombination for gene replacement in mouse cell lines. Methods Cell Biol 43:305-334
56. Witte ON 1993 Role of the Bcr-Abl oncogene in human leukemia: fifteenth Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 53:485-489
57. Yu H, Bauer B, Lipke GK, Phillips RL, Van Zant G 1993. Apoptosis and hematopoiesis in murine fetal liver. Blood 81:373-384